يعرض 1 - 10 نتائج من 24 نتيجة بحث عن '"A. O. Shmanev"', وقت الاستعلام: 1.01s تنقيح النتائج
  1. 1
    دورية أكاديمية
  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Cancer Urology; Том 19, № 3 (2023); 69-78 ; Онкоурология; Том 19, № 3 (2023); 69-78 ; 1996-1812 ; 1726-9776

    وصف الملف: application/pdf

    العلاقة: https://oncourology.abvpress.ru/oncur/article/view/1680/1481Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1254Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1255Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1256Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1257Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1260Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1261Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1680/1262Test; Martini T., Mayr R., Wehrberger C. et al. Comparison of radical cystectomy with conservative treatment in geriatric (≥80) patients with muscle-invasive bladder cancer. Int Braz J Urol 2013;39(5):622–30. DOI:10.1590/S1677-5538.IBJU.2013.05.03; Zeng S., Zhang Z., Yu X. et al. Laparoscopic versus open radical cystectomy for elderly patients over 75-year-old: a single center comparative analysis. PLoS One 2014;9:e98950. DOI:10.1371/journal.pone.0098950; Fontana P.P., Gregorio S.A., Rivas J.G. et al. Perioperative and survival outcomes of laparoscopic radical cystectomy for bladder cancer in patients over 70 years. Cent European J Urol 2015;68(1):24–9. DOI:10.5173/ceju.2015.01.498; Richards K.A., Kader A.K., Otto R. et al. Is robot-assisted radical cystectomy justifid in the elderly? A comparison of robotic versus open radical cystectomy for bladder cancer in elderly ≥75 years old. J Endourol 2012;26(10):1301–6. DOI:10.1089/end.2012.0035; Brodak M., Tomasek J., Pacovsky J. et al. Urological surgery in elderly patients: results and complications. Clin Interv Aging 2015;10:379–84. DOI:10.2147/CIA.S73381; Feng L., Song J., Wu M. et al. Extraperitoneal versus transperitoneal laparoscopic radical cystectomy for selected elderly bladder cancer patients: asingle center experience. Int braz J Urol 2016;42(4):655–62. DOI:10.1590/S1677-5538.IBJU.2015.0608; Serel T.A., Sevin G., Perk H. et al. Antegrade extraperitoneal approach to radical cystectomy and ileal neobladder. Int J Urol 2003;10(1):25–8. DOI:10.1046/j.1442-2042.2003.00560.x; Zhao J., Zeng S., Zhang Z. et al. Laparoscopic radical cystectomy versus extraperitoneal radical cystectomy: is the extraperitoneal technique rewarding? Clin Genitourin Cancer 2015;13(4):e271–7. DOI:10.1016/j.clgc.2015.01.006; Roth B., Birkhäuser F.D., Zehnder P. et al. Readaptation of the peritoneum following extended pelvic lymphadenectomy and cystectomy has a signifiant benefiial impact on early postoperative recovery and complications: results of a prospective randomized trial. Eur Urol 2011;59(2):204–10. DOI:10.1016/j.eururo.2010.10.030; Kulkarni J.N., Gulla R.I., Tongaonkar H.B. et al. Radical cystoprostatectomy: an extraperitoneal retrograde approach. J Urol 1999;161(2):545–8. DOI:10.1016/s0022-5347(01)61946-3; Verze P., Scuzzarella S., Martina G.R. et al. Long-term oncological and functional results of extraperitoneal laparoscopic radical prostatectomy: one surgical team’s experience on 1,600 consecutive cases. World J Urol 2013;31(3):529–34. DOI:10.1007/s00345-013-1052-0; Lei Y., Tong S., Zu X. et al. Extraperitoneal and transperitoneal laparoscopic partial cystectomy for benign non-urothelial bladder tumors: an initial experience. Urol Int 2015;94(2):149–55. DOI:10.1159/000366067; Zhu Y.P., Ye D.W., Yao X.D. et al. Defiing good candidates for extraperitoneal cystectomy: results from random peritoneum biopsies of 136 cases. Urology 2013;81(4):820–4. DOI:10.1016/j.urology.2012.11.057; Pakish D., Soliman P., Frumovitz M. et al. A comparison extraperitoneal versus transperitoneal laparoscopic para-aortic lymphadenectomy for staging endometrial carcinoma. Ginecol Oncol 2014;132(2):366–71. DOI:10.1016/j.ygyno.2013.12.019; Jensen J.B., Ulhøi B.P., Jensen K.M. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival. Int J Urol 2012;19(1):39–47. DOI:10.1111/j.1442-2042.2011.02887.x; Bi L., Huang H., Fan X. et al. Extended vs non-extended pelvic lymph node dissection and their inflence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studies. BJU Int 2014;113(5b):E39–48. DOI:10.1111/bju.12371; Larcher A., Sun M., Schiffmann J. et al. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. Eur J Surg Oncol 2015;41(3):353–60. DOI:10.1016/j.ejso.2014.10.061; Vakalopoulos I., Dimitriadis G., Anastasiadis A. et al. Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer? Int Urol Nephrol 2011;43(3): 743–8. DOI:10.1007/s11255-011-9904-2; https://oncourology.abvpress.ru/oncur/article/view/1680Test

  5. 5
    دورية أكاديمية

    المصدر: Cancer Urology; Том 18, № 1 (2022); 156-163 ; Онкоурология; Том 18, № 1 (2022); 156-163 ; 1996-1812 ; 1726-9776

    وصف الملف: application/pdf

    العلاقة: https://oncourology.abvpress.ru/oncur/article/view/1472/1354Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1472/1006Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1472/1007Test; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1472/1008Test; Penn I Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1994;99–109.; Gupta A.K., Cardella C.J., Haberman H.F. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol 1986;122(11):1288–93. DOI:10.1001/archderm.1986.01660230080015.; Penn I. Cancers in cyclosporine-treated vs azathioprine-treated patients. Transplant Proc 1996;28(2):876–78.; London N.J., Farmery S.M., Will E.J. et al. Risk of neoplasia in renal transplant patients. Lancet 1995;346(8972):403–6. DOI:10.1016/s0140-6736(95)92780-8.; Montaner S., Sodhi A., Molinolo A. et al. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi’s sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003;3(1):23–36. DOI:10.1016/s1535-6108(02)00237-4.; Stallone G., Schena A., Infante B. et al. Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 2005;352(13):1317–23. DOI:10.1056/NEJMoa042831.; Campistol J.M., Gutierrez-Dalmau A., Torregrosa J.V. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi’s sarcoma. Transplantation 2004;77(5):760–2. DOI:10.1097/01.tp.0000115344.18025.0b.; Peters T., Traboulsi D., Tibbles L.A., Mydlarski P.R. Sirolimus: a therapeutic advance for dermatologic disease. Skin Therapy Lett 2014;19(4):1–4.; Descoeudres B., Giannini O., Graf T. et al. No effect of sirolimus for Kaposi sarcoma in a renal transplant recipient. Transplantation 2006;81(10):1472–4. DOI:10.1097/01.tp.0000203322.99037.d2.; Александров И.В., Молочков В.А., Перлина А.Д. и др. Применение эверолимуса при лечении саркомы Капоши после трансплантации почки. Вестник трансплантологии и искусственных органов 2015;17(2):60–3. DOI:10.15825/1995-1191-2015-2-60-63.; Van den Akker J.M., Wetzels J.F., Hoitsma A.J. Proteinuria following conversion from azathioprine to sirolimus in renal transplant recipients. Kidney Int 2006;70(7):1355–7. DOI:10.1038/sj.ki.5001792.; Злокачественные новообразования в России в 2014 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2016. 250 с.; Hartevelt M.M., Bavinck J.N., Kootte A.M. et al. Incidence of skin cancer after renal transplantation in Netherlands. Transplantation 1990;49(3):506–9. DOI:10.1097/00007890-199003000-00006.; Sheil A.G., Disney A.P., Mathew T.G. et al. Malignancy following renal transplantation. Transplant Proc 1992;24(5):1946–7.; Bavinck J.N., De Boer A., Vermeer B.J. et al. Sunlight, keratotic skin lesions and skin cancer in renal transplant recipients. Br J Dermatol 1993;129(3):242–9. DOI:10.1111/j.1365-2133.1993.tb11841.x.; Penn I. Skin disorders in organ transplant recipients. External anogenital lesions. Arch Dermatol 1997;133(2):221–3.; Marks R., Jolley D., Lectsas S., Foley P. The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer. Med J Aust 1990;152(2):62–6. DOI:10.5694/j.1326-5377.1990.tb124456.x.; Dyall-Smith D., Ross J.B. Cutaneous malignancies in renal transplant recipients from Nova Scotia, Canada. Australas J Dermatol 1995;36(2):79–82. DOI:10.1111/j.1440-0960.1995.tb00937.x.; Gruber S.A., Gillingham K., Sothern R.B. et al. De novo cancer in cyclosporinetreated and non-cyclosporine-treated adult primary renal allograft recipients. Clin Transplant 1994;8(4):388–95.; LiddingtonM., RichardsonA.J., Higgins R.M. et al. Skin cancer in renal transplant recipients. Br J Surg 1989;76(10):1002–5. DOI:10.1002/bjs.1800761005.; Euvrard S., Kanitakis J., Pouteil-Noble C. et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995;33(2 Pt 1):222–9. DOI:10.1016/0190-9622(95)90239-2.; Naldi L., Fortina A.B., Lovati S. et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registrybased study. Transplantation 2000;70(10): 1479–84. DOI:10.1097/00007890200011270-00015.; Ramsay H.M., Fryer A.A., Reece S. et al. Clinical risk factors associated with nonmelanoma skin cancer in renal transplant recipients. Am J Kidney Dis 2000;36(1):167–76. DOI:10.1053/ajkd.2000.8290.; Barrett W.L., First M.R., Aron B.S., Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993;72(7):2186–9. DOI:10.1002/10970142(19931001)72:73.0.co;2-2.; Euvrard S., Chardonnet Y., Pouteil-Noble C. et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplantrecipients. Cancer 1993;72(7):2198–206. DOI:10.1002/1097-0142(19931001)72:73.0.co;2-q.; Moloney F.J., Comber H., O’Lorcain P. et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006;154(3):498–504. DOI:10.1111/j.1365-2133.2005.07021.x.; https://oncourology.abvpress.ru/oncur/article/view/1472Test

  6. 6
    دورية أكاديمية
  7. 7
  8. 8
    دورية أكاديمية
  9. 9
  10. 10